FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to medicine and concerns the tetrapeptide alanyl-glutamyl-aspartyl-leucine amide of the general formula Ala-Glu-Asp-Leu-NH2. Group of inventions also relates to the use of said tetrapeptide for restoring respiratory function and immunocorrection; pharmacological agent of a peptide nature restoring respiratory function and having an immunomodulatory effect, comprising an active peptide agent and a pharmaceutically acceptable carrier.
EFFECT: group of inventions provides a complex restorative effect on the function of the respiratory system, including immunocorrection.
3 cl, 6 dwg, 9 tbl, 9 ex
Authors
Dates
2018-09-19—Published
2017-11-27—Filed